Evidence map›Paper›PMID 38251102›Full record

ArticleNanomaterials (Basel, Switzerland)2024

Antimicrobial Activity of Two Different Types of Silver Nanoparticles against Wide Range of Pathogenic Bacteria.

Viktoriia Holubnycha, Yevheniia Husak, Viktoriia Korniienko, Svetlana Bolshanina, Olesia Tveresovska, Petro Myronov, Marharyta Holubnycha, Anna Butsyk, Thomas Borén, Rafal Banasiuk and 2 more

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Biosynthesis and Characterization ofNanomaterials (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Biogenesis ofInternational journal of molecular sciences · 2026
    Article
  5. AnACS applied bio materials · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Viktoriia HolubnychaMedical Institute, Sumy State University, 2, Rymskogo-Korsakova St., 40007 Sumy, Ukraine.
Yevheniia HusakMedical Institute, Sumy State University, 2, Rymskogo-Korsakova St., 40007 Sumy, Ukraine.
Viktoriia KorniienkoMedical Institute, Sumy State University, 2, Rymskogo-Korsakova St., 40007 Sumy, Ukraine.
Svetlana BolshaninaMedical Institute, Sumy State University, 2, Rymskogo-Korsakova St., 40007 Sumy, Ukraine.ORCID 0000-0002-9482-8620
Olesia TveresovskaMedical Institute, Sumy State University, 2, Rymskogo-Korsakova St., 40007 Sumy, Ukraine.
Petro MyronovMedical Institute, Sumy State University, 2, Rymskogo-Korsakova St., 40007 Sumy, Ukraine.
Marharyta HolubnychaMedical Institute, Sumy State University, 2, Rymskogo-Korsakova St., 40007 Sumy, Ukraine.
Anna ButsykDepartment Medical Biochemistry and Biophysics, Umeå University, SE-901 87 Umeå, Sweden.
Thomas BorénDepartment Medical Biochemistry and Biophysics, Umeå University, SE-901 87 Umeå, Sweden.
Rafal BanasiukNanoWave, 02-676 Warsaw, Poland.
Arunas RamanaviciusDepartment of Physical Chemistry, Institute of Chemistry, Faculty of Chemistry and Geosciences, Vilnius University, Naugarduko Str. 24, LT-03225 Vilnius, Lithuania.ORCID 0000-0002-0885-3556
Maksym PogorielovMedical Institute, Sumy State University, 2, Rymskogo-Korsakova St., 40007 Sumy, Ukraine.ORCID 0000-0001-9372-7791

Funding

ERA-NET JPIAMR-ACTION JTC 2022 VARIANTHorizon Europe MSCA-2021-SE-01project ARGO #101086441Latvian-Ukrainian Joint Programme of Scientific and Technological Cooperation Implementation of 2D bi-layered nanomembranes...Swedish Medical Research Council 2017-02183 and 2022-01295_3
6 · The paper itself

Abstract

The emergence of antibiotic-resistant bacteria, particularly the most hazardous pathogens, namely

Indexed as

antibiofilm activityantimicrobial activityESKAPE pathogenssilver nanoparticles

Identifiers

PMID38251102
PMCPMC10818322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.